Literature DB >> 1707090

Immunocytochemical double labeling of glial fibrillary acidic protein and transferrin permits the identification of astrocytes and oligodendrocytes in the rat brain.

S M Martin1, H B Landel, A J Lansing, V K Vijayan.   

Abstract

Sequential immunocytochemical double labeling of glial fibrillary acidic protein (GFAP) and transferrin (Tf) was used for the simultaneous identification of astrocytes and oligodendrocytes in paraffin-embedded sections of the rat brain. Paraformaldehyde or formalin-alcohol-acetic acid fixation followed by protease treatment of paraffin-embedded sections provided the most satisfactory double-labeling. The results demonstrated GFAP-positive astrocytes and Tf-positive oligodendrocytes as two subpopulations of glia with no overlap. Our results suggest that, with some exceptions, immunocytochemical double labeling of GFAP and Tf has a potential application for the simultaneous identification of astrocytes and oligodendrocytes in the rat brain.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1707090     DOI: 10.1097/00005072-199103000-00007

Source DB:  PubMed          Journal:  J Neuropathol Exp Neurol        ISSN: 0022-3069            Impact factor:   3.685


  3 in total

1.  Argyrophilic glial intracytoplasmic inclusions in multiple system atrophy: immunocytochemical and ultrastructural study.

Authors:  H Abe; S Yagishita; N Amano; K Iwabuchi; K Hasegawa; K Kowa
Journal:  Acta Neuropathol       Date:  1992       Impact factor: 17.088

2.  Immunocytochemical characterization of glial fibrillary tangles in Alzheimer's disease brain.

Authors:  M Nishimura; H Tomimoto; T Suenaga; Y Namba; K Ikeda; I Akiguchi; J Kimura
Journal:  Am J Pathol       Date:  1995-05       Impact factor: 4.307

3.  Permanent increase of immunocytochemical reactivity for gamma-aminobutyric acid (GABA), glutamic acid decarboxylase, mitochondrial enzymes, and glial fibrillary acidic protein in rat cerebral cortex damaged by early postnatal hypoxia-ischemia.

Authors:  H J Romijn; A W Janszen; C Van den Bogert
Journal:  Acta Neuropathol       Date:  1994       Impact factor: 17.088

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.